Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0154059 (
Esophagus
)
2,950
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Bcl-2/adenovirus E1B 19-kDa interacting protein (
BNIP3
), a pro-apoptosis protein regulated by the methylation status of its promoter, has been implicated in inducing autophagy. However, the roles of
BNIP3
and
BNIP3
-induced autophagy under hypoxia remain uncertain in esophageal squamous cell carcinoma (ESCC). Two esophageal squamous cancer cell lines, CAES17 and KYSE140, were selected on the basis of the expression and methylation status of
BNIP3
to investigate the features of
BNIP3
under hypoxia. Hypoxia increased cell death and the expression of
BNIP3
, whose promoter status was lower methylation, in a time-dependent manner.
BNIP3
knockdown by RNA interference downregulated cell death. These studies demonstrated that the exposure of ESCC cells to hypoxia increased the autophagic punctate distribution of MDC staining and GFP-LC3 and that autophagy rate could be inhibited by
BNIP3
-siRNA. In addition, under hypoxia, cells transfected with
BNIP3
-siRNA exhibited a lower apoptosis rate than the control, and the apoptosis induced by
BNIP3
exhibited a caspase-independent manner. Furthermore, the administration of the autophagic inhibitor 3-methyladenine (3-MA) could augment
BNIP3
-induced cell apoptosis and death, suggesting that autophagy plays a protective role under hypoxia. Together, our studies indicated that
BNIP3
exerts prodeath effects through the induction of caspase-independent apoptosis under hypoxia in ESCC, though
BNIP3
-induced autophagy acting as a survival mechanism.
Dis
Esophagus
2017 Sep 01
PMID:BNIP3 induces apoptosis and protective autophagy under hypoxia in esophageal squamous cell carcinoma cell lines: BNIP3 regulates cell death. 2885 61